Sugi Predict

Sugi Predict / Compounds / SCHEMBL4476383

SCHEMBL4476383

SCHEMBL4476383

COC(=O)C(CCSC)Nc1sc(C(=O)c2c(-c3ccccc3)noc2C)c(N)c1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.44
▸ LMNA P02545 7/20 0.44
▸ HPGD P15428 6/20 0.44
▸ GAA P10253 3/20 0.44
▸ POLB P06746 3/20 0.44
▸ HTT P42858 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ ALOX15 P16050 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ FNTA P49354 1/20 0.42
▸ FNTB P49356 1/20 0.42
▸ SMN1; SMN2 Q16637 6/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ PTBP1 P26599 3/20 0.42
▸ MELK Q14680 4/20 0.40
▸ TP53 P04637 1/20 0.40
▸ CYP3A4 P08684 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4477934 0.88 ALDH1A1 (0.46) ALDH1A1LMNAHPGDGAAPOLB
SCHEMBL4488267 0.81 MELK (0.44) ALDH1A1LMNAGAAMAPTKMT2A
SCHEMBL4478066 0.79 MELK (0.45) ALDH1A1LMNAGAAPOLBMAPT
SCHEMBL4476670 0.79 FNTA (0.41) ALDH1A1HPGDGAAPOLBMAPT
SCHEMBL4472280 0.78 ALDH1A1 (0.53) ALDH1A1LMNAHPGDGAAPOLB
SCHEMBL4485654 0.78 MELK (0.42) ALDH1A1GAAPOLBMAPTFNTA
SCHEMBL4466112 0.77 MELK (0.43) ALDH1A1GAAPOLBMAPTFNTA
SCHEMBL4472091 0.77 ALDH1A1 (0.47) ALDH1A1LMNAHPGDGAAPOLB
SCHEMBL4471914 0.77 MELK (0.46) ALDH1A1POLBMAPTFNTAFNTB
SCHEMBL4480478 0.76 ALDH1A1 (0.52) ALDH1A1LMNAHPGDGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-20060041006-A1 PDE4B inhibitors and uses therefor PLEXXIKON, INC. 2006-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PDE4B, PDE7B, PDE4A ALDH1A1 802/4885LMNA 2349/4885HPGD 319/4885
US-20060041006-A1 PDE4B inhibitors and uses therefor PDE4B, PDE7B, PDE4A ALDH1A1 802/4885LMNA 2349/4885HPGD 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.